Does Dr. SHANE GAILUSHAS have financial conflicts of interest?

Dr. SHANE GAILUSHAS (MD) has received a total of $2,394 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,394 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SHANE GAILUSHAS?

According to CMS Open Payments data, Dr. SHANE GAILUSHAS received funding from ACCLARENT ($1,015), INTEGRA LIFESCIENCES CORPORATION ($586), and GENZYME CORPORATION ($154).

Does Dr. SHANE GAILUSHAS receive research grants or speaking fees?

Dr. SHANE GAILUSHAS has received $2,394 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SHANE GAILUSHAS

MDReal-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: CEDAR RAPIDS, IA 52401

NPI Number: 1073786521

LIFETIME INDUSTRY VALUE

$2,394

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. GAILUSHAS is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in CEDAR RAPIDS, IA.

Between 2021 and 2024, Dr. GAILUSHAS had an overall industry promotional and research financial footprint of $2,394 as recorded in the federal CMS Open Payments database.

$2,394 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. GAILUSHAS's primary funding source is ACCLARENT, which accounts for $1,015 (representing 42.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ACCLARENT

Rank 1

$1,015

42.4%

INTEGRA LIFESCIENCES CORPORATION

Rank 2

$586

24.5%

GENZYME CORPORATION

Rank 3

$154

6.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.